Spark Therapeutics, Inc. Intellectual Property Contracts & Agreements
3 Contracts & Agreements
- License Agreements (3 contracts)
- License Agreement Amendment dated March 10, 2016 (effective November 23, 2015) amending and superseding the License Agreement between the Company and the Children's Hospital of... (Filed With SEC on February 28, 2019)
- License and Commercialization Agreement dated January 24, 2018 between the Registrant and Novartis Pharma AG (Filed With SEC on February 27, 2018)
- Amendment No. 2, dated November 6, 2017, to the License Agreement dated December 6, 2014 between the Registrant and Pfizer (Filed With SEC on February 27, 2018)
